AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 132 SEK 0.23% Market Closed
Market Cap: 16.1B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AddLife AB
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Effect of Foreign Exchange Rates
-kr6m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Effect of Foreign Exchange Rates
-kr10.9m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Effect of Foreign Exchange Rates
-kr4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Effect of Foreign Exchange Rates
-kr6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Effect of Foreign Exchange Rates
-kr248k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

AddLife AB
Glance View

Market Cap
16.1B SEK
Industry
Life Sciences Tools & Services

AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

ALIF B Intrinsic Value
161.83 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is AddLife AB's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-6m SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Effect of Foreign Exchange Rates amounts to -6m SEK.

What is AddLife AB's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
43%

The average annual Effect of Foreign Exchange Rates growth rates for AddLife AB have been 43% over the past three years .

Back to Top